These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8247636

  • 21. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

  • 22. [Moraxella catarrhalis as an important etiologic factor in infection of the lower bronchial tree].
    Nowak-Sadzikowska J, Heczko PB.
    Pneumonol Alergol Pol; 1994 Nov; 62(9-10):530-2. PubMed ID: 7866327
    [Abstract] [Full Text] [Related]

  • 23. [Perspective: new pathogens: Branhamella catarrhalis, Capnocytophaga turleri, Corynebacterium group JK].
    Saçilik SC.
    Mikrobiyol Bul; 1991 Oct; 25(4):381-6. PubMed ID: 1795663
    [Abstract] [Full Text] [Related]

  • 24. [Moraxella (Branhamella) catarrhalis. A common pathogenic agent].
    Prost J, Scavizzi M.
    Presse Med; 1991 Oct; 22(16):779-82. PubMed ID: 8316533
    [Abstract] [Full Text] [Related]

  • 25. [Prevalence of Moraxella catarrhalis colonization in asymptomatic carriers under 6 years of age].
    Leaños-Miranda B, Miranda-Novales MG, Solórzano-Santos F, Ortiz-Ocampo L, Guiscafré-Gallardo H.
    Salud Publica Mex; 2001 Oct; 43(1):27-31. PubMed ID: 11270281
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 27. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children.
    Korppi M, Katila ML, Jääskeläinen J, Leinonen M.
    Acta Paediatr; 1992 Dec; 81(12):993-6. PubMed ID: 1290865
    [Abstract] [Full Text] [Related]

  • 28. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature.
    Meyer GA, Shope TR, Waecker NJ, Lanningham FH.
    Clin Pediatr (Phila); 1995 Mar; 34(3):146-50. PubMed ID: 7774141
    [Abstract] [Full Text] [Related]

  • 29. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K, Chang BJ, Mee BJ, Riley TV.
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [Abstract] [Full Text] [Related]

  • 30. [Moraxella (Branhamella) catarrhalis: its isolation in the respiratory secretions of adult patients].
    Ferrer Marcellés A, Martínez Ojeda E, Falcó Ferrer V, de la Torre Tejedor E, González Fuente T.
    An Med Interna; 1997 Nov; 14(11):554-8. PubMed ID: 9445580
    [Abstract] [Full Text] [Related]

  • 31. Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):433-4. PubMed ID: 3137055
    [No Abstract] [Full Text] [Related]

  • 32. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
    Murphy TF.
    Expert Rev Vaccines; 2005 Dec; 4(6):843-53. PubMed ID: 16372880
    [Abstract] [Full Text] [Related]

  • 33. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Dec; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 34. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
    Ahmed A, Broides A, Givon-Lavi N, Peled N, Dagan R, Greenberg D.
    Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
    [Abstract] [Full Text] [Related]

  • 35. Branhamella catarrhalis respiratory infections.
    Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F.
    Eur Respir J; 1992 Jun; 5(6):675-9. PubMed ID: 1628725
    [Abstract] [Full Text] [Related]

  • 36. Moraxella catarrhalis respiratory infection in adults.
    Chin NK, Kumarasinghe G, Lim TK.
    Singapore Med J; 1993 Oct; 34(5):409-11. PubMed ID: 8153687
    [Abstract] [Full Text] [Related]

  • 37. [Neonatal conjunctivitis caused by Moraxella (Branhamella) catarrhalis].
    Sánchez F, Navarro F, Coll P.
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):515-6. PubMed ID: 1805961
    [No Abstract] [Full Text] [Related]

  • 38. [Branhamella catarrhalis: its respiratory pathogenicity in childhood].
    Moreno Galdo A, Ferrer Marcelles A, Aizpurúa Galdeano P, Navarro Aguirre M, Fernández Pérez F, Iglesias Berengue J.
    An Esp Pediatr; 1990 Aug; 33(2):135-9. PubMed ID: 2125809
    [Abstract] [Full Text] [Related]

  • 39. Moraxella catarrhalis endocarditis: case report and review of the literature.
    Stefanou J, Agelopoulou AV, Sipsas NV, Smilakou N, Avlami A.
    Scand J Infect Dis; 2000 Aug; 32(2):217-8. PubMed ID: 10826914
    [Abstract] [Full Text] [Related]

  • 40. Bronchopulmonary infection with Moraxella catarrhalis in infants requiring extracorporeal membrane oxygenation.
    Fenton AC, Foweraker JE, Pearson GA, Firmin RK.
    Pediatr Pulmonol; 1994 Jun; 17(6):393-5. PubMed ID: 8090611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.